Journal
AIDS
Volume 15, Issue 16, Pages 2191-2193Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/00002030-200111090-00017
Keywords
-
Categories
Ask authors/readers for more resources
In a randomized, parallel arm, open-label study, the effect of switching from ritonavir to either nelfinavir or nelfinavir plus saquinavir as part of a triple antiretroviral regimen was investigated in 16 patients with undetectable HIV-1 loads. Patients continued to use the same nucleoside reverse transcriptase inhibitors as before the switch of protease inhibitor. The period of follow-up was 48 weeks. In all patients HIV-1 load remained undectable, whereas CD4 cell counts remained stable. Furthermore, lipid markers improved after the switch.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available